Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Incyte Corp (NASDAQ:INCY)

102.02
Delayed Data
As of Dec 02
 +2.09 / +2.09%
Today’s Change
55.00
Today|||52-Week Range
118.49
-5.93%
Year-to-Date
3 Reasons Why Incyte Corporation Stock Could Soar in 2017
Dec 03 / MotleyFool.com - Paid Partner Content
Novo Nordisk's Diabetes Combination Drug Gets FDA's Nod
Nov 23 / Zacks.com - Paid Partner Content
Agenus' INCAGN1876 in Phase I/II Study for Solid Tumors
Dec 01 / Zacks.com - Paid Partner Content
When Will Gilead Sciences' Unlucky Streak End?
Nov 23 / MotleyFool.com - Paid Partner Content
3 Biotech Stocks to Buy in December
Dec 01 / MotleyFool.com - Paid Partner Content
AstraZeneca: FDA Lifts Hold on Head & Neck Cancer Trials
Nov 23 / Zacks.com - Paid Partner Content
3 Biotech Stocks to Buy on Sale
Nov 29 / MotleyFool.com - Paid Partner Content
Aduro Reports Partial Hold Lift on LADD Studies in U.S.
Nov 22 / Zacks.com - Paid Partner Content
Intellipharmaceutics Submits NDA for Pain Treatment Rexista
Nov 28 / Zacks.com - Paid Partner Content
Ligand's Partner Retrophin Provides New Data on Sparsentan
Nov 22 / Zacks.com - Paid Partner Content
Read This Before You Buy Any Marijuana Stocks
Nov 26 / MotleyFool.com - Paid Partner Content
Sanofi (SNY) Soliqua Approved for Type 2 Diabetes in Adults
Nov 22 / Zacks.com - Paid Partner Content
Merck (MRK) Announces 2.2% Increase in Quarterly Dividend
Nov 24 / Zacks.com - Paid Partner Content